Gilead Sciences, Inc.
Gilead Sciences Partners With Cognizant for DevOps
·Consolidated from 1 source
Gilead Sciences has entered into a five-year agreement with Cognizant to enhance its DevOps capabilities. This strategic partnership aims to streamline and improve the company's technology operations. The collaboration is expected to drive efficiency and innovation within Gilead's digital infrastructure.
Gilead Sciences has announced a significant five-year partnership with Cognizant, a leading provider of IT services and consulting. The agreement focuses on leveraging Cognizant's expertise in DevOps to transform Gilead's technology development and operational processes.
DevOps, a set of practices that combines software development and IT operations, is crucial for businesses seeking to accelerate product delivery, improve quality, and enhance system reliability. By engaging Cognizant, Gilead Sciences aims to modernize its IT infrastructure and workflows, fostering a more agile and efficient environment for its technology teams.
This collaboration is expected to enable Gilead to better respond to the rapidly evolving needs of the biopharmaceutical industry. Reports suggest that the partnership will focus on areas such as continuous integration, continuous delivery, and automation, all key components of a robust DevOps strategy. The goal is to create a more seamless and responsive development lifecycle.
The five-year term of the agreement indicates a long-term commitment from both companies to achieve substantial improvements in Gilead's operational technology. While specific details of the implementation were not disclosed, the partnership signals Gilead's ongoing investment in digital transformation to support its research, development, and commercial activities.
Sources
This recap was generated by consolidating the public headlines below.